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Huntington disease (HD) is a common autosomal dominant neurodegenerative disease with early adult–onset motor
abnormalities and dementia. Many studies of HD show that huntingtin (CAG)n repeat–expansion length is a sensitive
and specific marker for HD. However, there are a significant number of examples of HD in the absence of a
huntingtin (CAG)n expansion, suggesting that mutations in other genes can provoke HD-like disorders. The iden-
tification of genes responsible for these “phenocopies” may greatly improve the reliability of genetic screens for
HD and may provide further insight into neurodegenerative disease. We have examined an HD phenocopy pedigree
with linkage to chromosome 20p12 for mutations in the prion protein (PrP) gene (PRNP). This reveals that affected
individuals are heterozygous for a 192-nucleotide (nt) insertion within the PrP coding region, which encodes an
expanded PrP with eight extra octapeptide repeats. This reveals that this HD phenocopy is, in fact, a familial prion
disease and that PrP repeat-expansion mutations can provoke an HD “genocopy.” PrP repeat expansions are well
characterized and provoke early-onset, slowly progressive atypical prion diseases with an autosomal dominant
pattern of inheritance and a remarkable range of clinical features, many of which overlap with those of HD. This
observation raises the possibility that an unknown number of HD phenocopies are, in fact, familial prion diseases
and argues that clinicians should consider screening for PrP mutations in individuals with HD-like diseases in which
the characteristic HD (CAG)n repeat expansions are absent.
Huntington disease (HD [MIM 143100]) is an autoso-
mal dominant neurodegenerative disease characterized
by chorea, rigidity, and progressive dementia. A world-
wide study of HD revealed (CAG)n repeat–expansion
length in the huntingtin protein (GenBank accession
number AAB38240) to be a sensitive and specific marker
for the disease (Kremer et al. 1994). However, at least
one study has reported cases of HD without CAG ex-
pansions (Andrew et al. 1994), suggesting the presence
of HD phenocopies (MIM 603218). The possibility that
mutations in other genes are capable of provoking an
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illness similar to HD has important implications for ge-
netic testing.
Investigation of a pedigree, affected with an HD phe-
nocopy, that lacked the characteristic HD (CAG)n ex-
pansion revealed autosomal dominant inheritance and
linkage (LOD 3.01) to a 2.7-cM interval on chromosome
20p12 (Xiang et al. 1998). This region encodes the prion
protein (PrP [MIM 176640; GenBank accession number
BAA00011]) and contains a number of other plausible
candidate genes, which were screened and were initially
found to be normal in this family. Nevertheless, this
region remains a candidate locus for an HD-like disease,
and it has been suggested that studies involving HD phe-
nocopies should examine this region for linkage (Les-
perance and Burmeister 2000).
The recent discovery of a PrP-like gene, doppel or
Prnd (MIM 604263; GenBank accession number
NP_036541]), 16 kb downstream of the PrP gene in mice
(Prnp) and humans (PRNP) (Moore et al. 1999), sug-
gested a new candidate gene for this HD phenocopy. We
therefore examined this region in the family with this
HD phenocopy for mutations in the PRND coding re-
1386 Am. J. Hum. Genet. 69:1385–1388, 2001
Figure 1 Alignment of the wild-type and mutant PrP peptide sequences from a single individual from the HD phenocopy pedigree showing
the eight-repeat expansion. The expanded repeats are shown below the wild-type sequence and are numbered according to silent substitutions
in the DNA sequences. Wild-type human PrP contains one PQGGGGWGQ nonapeptide (encoded by R1) and four PHGGGWGQ octapeptides
(encoded by R2-R4), such that the normal sequence is R1-R2-R2-R3-R4. The mutant allele has eight extra PHGGGWGQ repeats: R1-R2-R2-
R3g-R2-R2-R2-R3g-R3g-R2-R2-R3-R4. Both alleles encode methionine at codon 129.
gion. We also sequenced a region containing the terminal
exon of PrP, together with the splice sites and 3′ UTR
to screen for novel noncoding mutations in PRNP.
We examined both genes in four affected and one un-
affected members of the family. The PRND open reading
frame (ORF) was normal; however, analysis of the PRNP
ORF revealed a 192-bp in-frame octapeptide repeat ex-
pansion in all affected family members examined. In all
cases, the mutation was on an allele encoding methionine
at PrP residue 129. All affected members were hetero-
zygous, consistent with the autosomal dominant pattern
of inheritance in this family. The mutation was the result
of an expansion within the N-terminal repeat region of
PrP. Although the wild-type PrP allele consists of five re-
peats between codons 51 and 91, the mutant allele is
predicted to generate an elongated PrP with a total of 13
N-terminal repeats (fig. 1). These repeats have been clas-
sified into four main types, and the normal sequence is
R1-R2-R2-R3-R4 (Kretzschmar et al. 1986), in which R1
encodes the nonapeptide PQGGGGWGQ and R2–R4 en-
code the octapeptide PHGGGWGQ. On the basis of this
classification scheme, the repeats in the elongated PrP
from the mutant allele had the sequence R1-R2-R2-R3g-
R2-R2-R2-R3g-R3g-R2-R2-R3-R4, in which repeat R3g
contains a silent nucleotide substitution.
Taken together with the original study showing pos-
itive linkage (LOD 3.01) to markers D20S193–D20S895
on chromosome 20p (Xiang et al. 1998), the PrP repeat
expansion described here appears to be responsible for
the HD phenocopy in this family. Indeed, PrP repeat-
expansion mutations involving 2, 4, 5, 6, 7, 8, 9, and
10 extra repeats have been described in other patients
with progressive dementia and ataxia (Goldfarb et al.
1991; Owen et al. 1992; Duchen et al. 1993; Krasemann
et al. 1995; Gambetti et al. 1999). A mutation involving
an expansion of eight extra repeats that is similar to that
in the family described here, with an HD-like presen-
tation, has been described in a large French family, re-
ferred to as family “M-E,” with “prominent psychiatric
features” (Laplanche et al. 1999). Comparison with the
HD phenocopy family reveals that the disease presen-
tation is similar and that many of the apparent differ-
ences may be caused by the relative emphasis placed on
psychiatric versus neurological aspects of the disease.
Broadly speaking, carriers of the PrP repeat insertion in
family M-E presented with a disease with early adult
psychiatric or behavioral disturbance, followed by neu-
rological problems and dementia (Laplanche et al.
1999). Multiple members of the HD phenocopy kindred
also developed behavioral and psychiatric disturbances,
including personality change, depression, aggressiveness,
and delusional thoughts (Xiang et al. 1998), often prior
to or concomitant with neurological symptoms. These
observations are consistent with a common PRNP re-
peat size of 192 bp, which encodes a PrP with eight
extra octapeptide repeats on a methionine 129 allele.
Transgenic mice expressing PrP with 14 octapeptide
repeats (Chiesa et al. 1998, 2000) developed an early-
onset ataxia, but the disease was not demonstrated to
be transmissible. However, brain homogenates from in-
dividuals with five, seven, and eight extra PrP octapep-
tide repeats have transmitted disease to primates (Brown
et al. 1994)—strongly suggesting that PrP with repeat
expansions provokes bona fide prion diseases.
The disorder in the phenocopy kindred has a number
of characteristics suggestive of classical HD: an early
adult onset (age range 23–41 years; mean 29.7 years),
autosomal dominant syndrome consisting of personality
change, cognitive decline, motor disturbance with cho-
rea, dysarthria, and ataxia, together with atrophy of the
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basal ganglia. In the absence of the characteristic hun-
tingtin (CAG)n repeat expansion, it was considered to
be an HD “phenocopy.” A diagnosis of prion disease
was originally considered but was excluded on the basis
of a normal PrP sequence. We now know that affected
members were heterozygous for a PrP repeat expansion.
Although sporadic Creutzfeldt-Jakob disease (CJD) is
usually considered to be a late-onset disorder with a
rapid progression, familial CJD can have a significantly
earlier age of onset with a more prolonged duration.
This is particularly apparent in individuals with PrP re-
peat expansions, who tend to have an age at onset sim-
ilar to that in HD. A number of similar factors, such as
early age at onset and the exceptionally broad range of
clinical presentations, means that familial CJD can be
mistaken for HD. Chorea, although rare in sporadic CJD
and most familial forms of CJD, was present in several
affected members of a large English kindred with six
extra PrP repeats (Collinge et al. 1992; Poulter et al.
1992). This kindred also contained at least one individ-
ual who had been diagnosed with HD. In the HD phe-
nocopy pedigree described here, chorea seems to have
been a more prominent clinical feature, being present in
four of six affected individuals (Xiang et al. 1998).
We suggest that individuals presenting with HD or
HD-like diseases should be screened for PrP mutations
if the huntingtin (CAG)n repeat length is within the nor-
mal range, especially when clinical signs atypical of HD
are present. Many of the known HD phenocopy patients
have atypical features (Andrew et al. 1994), and, in ret-
rospect, we recognize that members of the phenocopy
kindred reported here had clinical features atypical of
HD, such as epileptic seizures.
The PRNP ORF is encoded by a single exon (Puckett
et al. 1991; Lee et al. 1998) and can be sequenced with
relative ease. PCR assays capable of detecting the ex-
panded allele can be unreliable, because there is often
selective amplification of the wild-type allele so that the
relatively weak signal from the enlarged allele can be
overlooked easily in cases of repeat expansion. It is likely
that this was responsible for the original false negative
PrP screen in this family (Xiang et al. 1998). One prac-
tical solution, in the absence of a suitable positive con-
trol, is to amplify and sequence a larger region contain-
ing the entire PrP terminal exon, because (in our
experience) this seems to avoid the selective amplifica-
tion of the wild-type allele from such cases. Primer po-
sition is also important, as there are SNPs near the intron
1/exon 2 junction that have been shown to be respon-
sible for the failure to amplify some rare alleles with
primer mismatches (Palmer et al. 1996) in this region.
Our observation that this HD phenocopy is, in fact,
a prion disease implies that an unknown proportion of
patients with the HD phenocopy might have PrP mu-
tations. Tissues from patients with HD phenocopies who
have PrP mutations may therefore represent a potential
source of infection to health care workers and to recip-
ients of blood and tissue donations.
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